Ozempic Copies Drive Down Obesity Drug Prices in Canada

Novo Nordisk, the manufacturer of the popular obesity drug Ozempic, has suffered a costly setback in Canada as copycat drugs, priced at about a quarter of the original, have entered the market.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

helsingin-sanomatFinnish68d ago

Laihdutuslääkkeet | Ozempic-kopiot romahduttavat lihavuuslääkkeiden hinnat Kanadassa

Suosituimman lihavuuslääkkeen valmistajalle Novo Nordiskille sattui Kanadassa kallis vahinko. Myyntiin päässeet kopiolääkkeet maksavat noin neljäsosan alkuperäisen hinnasta.

Read full article →

PERSPECTA

PERSPECTA

Ozempic Copies Drive Down Obesity Drug Prices in Canada

Sources

Laihdutuslääkkeet | Ozempic-kopiot romahduttavat lihavuuslääkkeiden hinnat Kanadassa

Related Stories

ASUS and Coherent Report Strong Growth Driven by AI Server Demand

Ford to Shift Lincoln Production from China to US by 2030

BUX Index Closes at Historic High in Hungary

Leadership Turmoil and Transition at Tata Sons

PERSPECTA